U.S. Embassy in Gabon

U.S. Embassy in Gabon

U.S. Embassy Libreville announces the donation by the United States Government of 100,620 doses of the Pfizer COVID-19 vaccine as part of the Administration’s global efforts to fight the COVID-19 pandemic. The United States has already donated more than 160 million doses from its domestic supply to over 100 countries.  The U.S. Government coordinated closely with the African Union and Africa Centers for Disease Control and Prevention on the country allocations. The vaccine doses arrived via COVAX last night.

The vaccines will help protect the Gabonese people from the ravages of the COVID-19 virus and reduce barriers to building back the Gabonese economy. “These vaccines represent hope for a brighter future, and we are proud to continue working together with the Gabonese Government, the private sector, and civil society to do everything we can to mitigate the pandemic’s high toll on lives and livelihoods, and its social impacts,” remarked Chargé d’Affaires, a.i., Christopher Tremann. “I urge each of you to get vaccinated at the earliest opportunity – as I have – and remain vigilant; through vaccination, we protect ourselves, each other, and the most vulnerable among us.”

These 100,620 doses are part of the Biden-Harris Administration commitment to share U.S. vaccine supply with the world. As we continue to fight the COVID-19 pandemic at home and work to end the pandemic worldwide, President Biden has promised that the United States will be an arsenal of vaccines for the world.

As President Biden said,

From the beginning of my presidency, we have been clear-eyed that we need to attack this virus globally as well. This is about our responsibility — our humanitarian obligation to save as many lives as we can — and our responsibility to our values. We’re going to help lead the world out of this pandemic, working alongside our global partners.”

Distributed by APO Group on behalf of U.S. Embassy in Gabon.

Send us your press releases to pressrelease.zawya@refinitiv.com

© Press Release 2021

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.